DK170501B1 - System for irradiation of certain cancers with broad-spectrum radiation through optical fibers and optical probes for use in the system - Google Patents
System for irradiation of certain cancers with broad-spectrum radiation through optical fibers and optical probes for use in the system Download PDFInfo
- Publication number
- DK170501B1 DK170501B1 DK141092A DK141092A DK170501B1 DK 170501 B1 DK170501 B1 DK 170501B1 DK 141092 A DK141092 A DK 141092A DK 141092 A DK141092 A DK 141092A DK 170501 B1 DK170501 B1 DK 170501B1
- Authority
- DK
- Denmark
- Prior art keywords
- radiation
- optical
- probe
- fibers
- probes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Radiation-Therapy Devices (AREA)
Description
Λ DK 170501 B1Λ DK 170501 B1
Opfindelsen angår et system til bestråling af cancerramt væv med bredspektret IR-/ og UV-stråling, uden at bestråle rask cellevæv. Strålingen foregår gennem optiske fibre, der indføres i eller i umiddelbar nærhed af det 5 cancerramte cellevæv ved hjælp af optiske prober/kanyler. Opfindelsen angår endvidere optiske prober til brug i systemet.The invention relates to a system for irradiating cancerous tissue with broad-spectrum IR / and UV radiation, without irradiating healthy cellular tissue. The radiation takes place through optical fibers that are introduced into or in the immediate vicinity of the cancerous cell tissue by optical probes / needles. The invention further relates to optical probes for use in the system.
Anvendelse af stråleteknik til påvirkning af levende væv med hypertermi til en kontrolleret ophedning (40°-45°) er 10 en forholdsvis ny teknik, men har vist sig at sensitere virkningen af traditionel ioniserende strålebehandling.The use of radiation techniques to influence living tissue with hyperthermia for controlled heating (40 ° -45 °) is a relatively new technique, but has been shown to sensitize the effect of traditional ionizing radiation therapy.
Imidlertid har der været store problemer forbundet med kun at opvarme det cancerramte område og ikke det 15 omkringliggende raske cellevæv.Der findes defor mange metoder til fremføring af hypertermi, f.eks.: R.F. radiobølger, microbølger, magnetisk påvirkning, ultralyd og varmtvandslednings-teknik, se f.eks. Tor Vergata Monograph Series Vol4 1993 Hyperthermia og E.S.H.O. June 20 1993, Brussels Book of Abstracts.However, there have been major problems in heating only the cancerous area and not the surrounding healthy cell tissue. There are therefore many methods of transmitting hyperthermia, for example: R.F. radio waves, microwaves, magnetic effects, ultrasound and hot water technology, see e.g. Tor Vergata Monograph Series Vol4 1993 Hyperthermia and E.S.H.O. June 20 1993, Brussels Book of Abstracts.
Vamrtvandssystemet er afhængigt af lederevnen ved varme-overførsien og har næsten ingen dybdevirkning.The wastewater system is dependent on the conductivity of the heat transfer and has almost no depth effect.
De andre metoder er alle nødvendigvis komplicerede i 25 design og brug og kræver komplekse kanyler der er følsomme overfor små forandringer i parametrene, samt overfor belastningsimpedans-effekt.The other methods are all necessarily complicated in design and use and require complex needles that are sensitive to small changes in parameters, as well as to load impedance effect.
Fra U.S. patentskrift nr.5.151.096, U.S. patentskrift nr.: 30 5.050.597 og D.D. patentskrift nr.: 296.616 kendes der DK 170501 B1 systemer, hvor der benyttes en laser som stråingskilde.From the U.S. U.S. Patent No. 5,151,096, U.S. U.S. Patent No. 30,050,597 and D.D. Patent No. 296,616 discloses DK 170501 B1 systems using a laser as a radiation source.
Laser systemer arbejder med enkelte bølgelængder og kræver komplicerede kilder, kontrol og sommetider vandafkøling af kanyler, f.eks som vist i U.S. patentskrift nr.5.050.597., 5 til styring af den involverede energi, til sikring af temperaturmæssig ensartethed i området og til modvirkning * af sekundære varmeeffekter fra fremføringen.Laser systems operate at single wavelengths and require complicated sources, control, and sometimes water cooling of needles, for example, as shown in U.S. Pat. No. 5,050,597., 5 to control the energy involved, to ensure temperature uniformity in the area and to counteract * secondary heat effects from the feed.
Så komplekse kanyler som sådanne systemer kræver, er 10 vanskelige både at fremstille og at indføre p.g.a. deres størrelse og form, mens direkte laser-bestråling af et område medfører uønskede hypertermiske bivirkninger fra det påvirkede væv overført til det omgivende raske væv, som kan blive nedbrudt under processen.As complex needles as such systems require, 10 are difficult both to manufacture and to introduce p.g.a. their size and shape, while direct laser irradiation of an area causes unwanted hyperthermic side effects from the affected tissue transmitted to the surrounding healthy tissue, which can be degraded during the process.
15 Ovennævnte ulemper undgåes med et system ifølge opfindelsen, som er særegent ved det, der er angivet i den kendetegnende del af krav 1, og ved prober ifølge opfindelsen, som er særegne ved det, der er angivet i den kendetegnende del af krav 2.The above-mentioned drawbacks are avoided by a system according to the invention, which is peculiar to that of the characterizing part of claim 1, and by probes according to the invention which are peculiar to that of the characterizing part of claim 2.
2020
Systemet ifølge opfindelsen som beskrives i det følgende er grundlæggende forskelligt fra de ovenfor omtalte derved, at det er forholdsvis enkelt i design, fremstilling og anvendelse.The system according to the invention described below is fundamentally different from those mentioned above in that it is relatively simple in design, manufacture and use.
25 Det arbejder med bredbånds infrarød energi i området * 700 -10.000 nm og/eller ultra-violet stråling i området 100 - 400 nm, der transmitteres fra strålingskilden til behandlingsområdet via optiske fibre, der ved hjælp af optiske prober/kanyler indføres direkte i eller i umiddel- 30 bar nærhed af det cancerramte væv.25 It works with broadband infrared energy in the range * 700 -10.000 nm and / or ultraviolet radiation in the range 100 - 400 nm transmitted from the radiation source to the treatment area via optical fibers introduced directly into or through optical probes / needles. in the immediate vicinity of the cancerous tissue.
Proberne er lette at indføre på grund af deres beskedne størrelse og enkle form. Proberne kræver ikke nogen form for afkøling.The probes are easy to insert due to their modest size and simple shape. The probes do not require any kind of cooling.
DK 170501 B1DK 170501 B1
Proberne designes med både symmetriske og asymmetriske 5 strålingsfelter under hensyn til deres længdeakse som tillader bestråling af området med nedsat eller helt bortfalden risiko for uønsket bestråling af tilstødende væv.The probes are designed with both symmetrical and asymmetric radiation fields, taking into account their longitudinal axis which allows irradiation of the area with reduced or completely eliminated risk of unwanted irradiation of adjacent tissue.
10 Temperaturstigningen i området er hurtig og ensartet med god gennemtrængningsdybde og opnåes udelukkende ved stråling og påvirkes ikke af nogen form for konduktion.10 The temperature rise in the area is rapid and uniform with good penetration depth and is achieved only by radiation and is not affected by any kind of conductance.
I probens design er også indbygget adgang til at fremføre 15 hypertermi ved infrarød energi fra een kilde med den valgmulighed samtidig at bestråle området med ultraviolet energi indenfor 100 - 400 nm som ekstra behandling tilført fra en separat kilde men i samme probe.In the design of the probe there is also built-in access to transmit 15 hyperthermia by infrared energy from one source with the option of simultaneously irradiating the area of ultraviolet energy within 100 - 400 nm as extra treatment supplied from a separate source but in the same probe.
UV-bestrålingen i de ovenfor nævnte bølgelængder virker 20 kombineret med IR-strålingen nedbrydende på cellevævet i bestrålingsområdet. Endvidere virker UV-strålingen forstærkende ved simultan behandling med kemoterapi hvori der anvendes lysaktiverede celledræbende stoffer.The UV radiation in the aforementioned wavelengths acts in combination with the IR radiation degrading on the cellular tissue in the radiation area. Furthermore, the UV radiation is potentiating by simultaneous treatment with chemotherapy using light-activated cell-killing agents.
25 I proberne er der udover fibrene til IR-/UV-strålingen også indlagt lysledende og billeddannende fibre, således at man via kamera på tilsluttet monitor kan følge at proberne bliver rigtigt placeret.25 In addition to the fibers for the IR / UV radiation, the probes also incorporate light-conducting and imaging fibers, so that the probes can be placed correctly via the camera on the connected monitor.
Behandlingsforløbet kan hele tiden følges og kontrolleres 30 via monitor.The course of treatment can be constantly monitored and monitored via monitor.
DK 170501 B1 I proberne er endvidere indlagt kommunikations-fibre tilsluttet styreenhed til kontrolformål.In addition, communication fibers are connected to the control unit for control purposes in the probes.
Gennem disse fibre aflæses og styres en konstant temperatur på behandlingsområdet samtidig med at afgivelse 5 af strålemængde kontrolleres.Through these fibers, a constant temperature in the treatment area is read and controlled while controlling the amount of radiation 5.
irir
Med henvisning til tegningen forklares opfindelsen nærmere i det følgende, hvor Fig.l viser et blokdiagram over et 10 system ifølge opfindelsen, og Fig.2 viser forskellige udformninger af proben ifølge opfindelsen.With reference to the drawing, the invention is explained in more detail below, where Fig. 1 shows a block diagram of a system according to the invention, and Fig. 2 shows various embodiments of the probe according to the invention.
Fra et strålingsmodul (1) indeholdende lyskilder med paraboler og optik, udsendes bredspektret IR-stråling i et område fra 700 - 10000 nm.From a radiation module (1) containing light sources with parabolas and optics, broad-spectrum IR radiation is emitted in a range from 700 - 10000 nm.
15 Strålerne transporteres fra et eller flere udtag (6) via connectorer (8) gennem optiske fibre (11), der er velegnet til IR-transmission.The rays are transported from one or more outlets (6) via connectors (8) through optical fibers (11) suitable for IR transmission.
Fra et strålingsmodul (2) indeholdende glødetråde/lysbuer 20 med paraboler og quartzoptik, udsendes bredspektret UV-stråling i et område fra 100 - 400 nm.From a radiation module (2) containing filaments / arcs 20 with parabolas and quartz optics, broad-spectrum UV radiation is emitted in a range of 100 - 400 nm.
Strålerne transporteres fra et eller flere udtag (4) via connector (9) gennem optiske fibre (10), der er velegnet I* til UV-transmission.The rays are conveyed from one or more outlets (4) via connector (9) through optical fibers (10) suitable for I * for UV transmission.
25 s25 s
De optiske fiberbundter (10 og 11) bliver i fordelingsstykket (12) sammen med billed/lys- og kommunikationsfibre (15 og 16) (til kontrolformål) i små bundter blandet og fordelt ud i mindre forgreninger, der indlægges i optiske 30 prober (13).The optical fiber bundles (10 and 11), in the distribution piece (12), together with image / light and communication fibers (15 and 16) (for control purposes) are mixed into small bundles and distributed into smaller branches which are inserted into optical probes (13 ).
DK 170501 B1DK 170501 B1
Afslutningerne på proberne med de indlagte fibre (13) slibes og poleres i bestemte vinkler for at strålerne kan afgives i forudbestemte retninger.(Fig. 2) 5 Strålingsmængden for henholdsvis IR-stråling og UV-stråling reguleres af styreenhed (18) der er forbundet med computer (21).The ends of the probes with the inserted fibers (13) are abraded and polished at certain angles for the rays to be emitted in predetermined directions. (Fig. 2) The amount of radiation for IR radiation and UV radiation, respectively, is controlled by the control unit (18) connected. with computer (21).
Billeddannende fibre (15) og kommunikationsfibre (16) er 10 gennem fordelingsstykket (12) indlagt i de optiske prober (13) sammen med de strålingsførende fibre (10 og 11).Imaging fibers (15) and communication fibers (16) are inserted through the distributor (12) into the optical probes (13) together with the radiation conducting fibers (10 and 11).
Via de billeddannende fibre (15) kan man ved hjælp af kamera (19) følge forløbet af behandlingen på monitor (17) 15 Gennem kommunikationsfibrene (16) kan man via styreenhed (18) på printer (22) og monitor (23) hele tiden aflæse den på behandlingsstedet afgivne strålingsmængde og registrere temperaturen på det behandlede område.Via the imaging fibers (15), one can monitor the process of the monitor (17) by means of the camera (19) 15 Through the communication fibers (16), the control unit (18) of the printer (22) and the monitor (23) can be used at all times. read the amount of radiation emitted at the treatment site and record the temperature of the treated area.
2020
Claims (3)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK141092A DK170501B1 (en) | 1992-11-24 | 1992-11-24 | System for irradiation of certain cancers with broad-spectrum radiation through optical fibers and optical probes for use in the system |
PCT/DK1993/000378 WO1994012240A1 (en) | 1992-11-23 | 1993-11-18 | Systems for irradiation of cancer with broad spectrum radiation by means of optic fibres and optic probes |
EP94900775A EP0626870A1 (en) | 1992-11-23 | 1993-11-18 | Systems for irradiation of cancer with broad spectrum radiation by means of optic fibres and optic probes |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK141092A DK170501B1 (en) | 1992-11-24 | 1992-11-24 | System for irradiation of certain cancers with broad-spectrum radiation through optical fibers and optical probes for use in the system |
DK141092 | 1992-11-24 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK141092D0 DK141092D0 (en) | 1992-11-24 |
DK141092A DK141092A (en) | 1994-05-25 |
DK170501B1 true DK170501B1 (en) | 1995-10-02 |
Family
ID=8104534
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK141092A DK170501B1 (en) | 1992-11-23 | 1992-11-24 | System for irradiation of certain cancers with broad-spectrum radiation through optical fibers and optical probes for use in the system |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0626870A1 (en) |
DK (1) | DK170501B1 (en) |
WO (1) | WO1994012240A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8109981B2 (en) | 2005-01-25 | 2012-02-07 | Valam Corporation | Optical therapies and devices |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4170997A (en) * | 1977-08-26 | 1979-10-16 | Hughes Aircraft Company | Medical laser instrument for transmitting infrared laser energy to a selected part of the body |
US4622972A (en) * | 1981-10-05 | 1986-11-18 | Varian Associates, Inc. | Ultrasound hyperthermia applicator with variable coherence by multi-spiral focusing |
GB2154761A (en) * | 1984-02-21 | 1985-09-11 | Quentron Optics Pty Ltd | Diffusive optical fibre termination |
US4612940A (en) * | 1984-05-09 | 1986-09-23 | Scd Incorporated | Microwave dipole probe for in vivo localized hyperthermia |
AU602123B2 (en) * | 1985-05-17 | 1990-10-04 | Laser Holdings Limited | Optical therapeutic and surgical system |
-
1992
- 1992-11-24 DK DK141092A patent/DK170501B1/en not_active IP Right Cessation
-
1993
- 1993-11-18 EP EP94900775A patent/EP0626870A1/en not_active Withdrawn
- 1993-11-18 WO PCT/DK1993/000378 patent/WO1994012240A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1994012240A1 (en) | 1994-06-09 |
DK141092A (en) | 1994-05-25 |
EP0626870A1 (en) | 1994-12-07 |
DK141092D0 (en) | 1992-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2566553C (en) | System and method for therapy and diagnosis comprising optical components for distribution of radiation | |
US6527764B1 (en) | Device and method for laser biomodulation in PDT/surgery | |
CN111050682B (en) | Non-ablative photonic devices and related methods | |
US9205278B2 (en) | Method of providing uniform distribution of light in a phototherapy device | |
JPH0363915B2 (en) | ||
Ivarsson et al. | Feedback interstitial diode laser (805 nm) thermotherapy system: Ex vivo evaluation and mathematical modeling with one and four‐fibers | |
CN115551556B (en) | Remote eradication of pathogens | |
US11331145B2 (en) | Device for laser thermal ablation with a diffusing catheter and equipment comprising said device | |
US11147625B2 (en) | Device for laser thermal ablation with centering means and equipment comprising said device | |
US6503268B1 (en) | Therapeutic laser system operating between 1000nm and 1300nm and its use | |
JP6076847B2 (en) | Laser therapy device | |
US20220249162A1 (en) | Device for inducing cell death | |
US11135011B2 (en) | Device for laser thermal ablation with a helically shaped diffuser and equipment comprising said device | |
DK170501B1 (en) | System for irradiation of certain cancers with broad-spectrum radiation through optical fibers and optical probes for use in the system | |
US10617471B2 (en) | Laser therapeutic device | |
JP2023527680A (en) | Time multiple dosimetry system and method | |
EP0649667A2 (en) | Quantum energy therapeutic biostimulation method and apparatus | |
US20050159794A1 (en) | Multiple port photodynamic therapy irradiation system | |
LT6795B (en) | Laser therapy fiber optic probe | |
McKenzie | How may external and interstitial illumination be compared in laser photodynamic therapy? | |
KR101924492B1 (en) | Medical light irradiation and monitoring equipment | |
Waldow et al. | Response of the RIF-1 tumour to superficial or interstitial heating (46–50° C) using an Nd-YAG laser | |
Panjehpour et al. | Nd: YAG laser-induced interstitial hyperthermia | |
RU4911U1 (en) | MEDICAL LASER INSTALLATION | |
Austerlitz et al. | Short and long term stability of the Diomed 630PDT laser evaluated with integrating sphere, power meter, and calorimeter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A0 | Application filed | ||
B1 | Patent granted (law 1993) | ||
PBP | Patent lapsed |